Search results for "Highlights"
Insulin pump didn't improve glycemic control compared to training on injections
British patients with type 1 diabetes were enrolled in group training courses that taught flexible intensive insulin treatment and then randomized to an insulin pump or multiple daily injections and followed for two years.
https://diabetes.acponline.org/archives/2017/04/14/3.htm
14 Apr 2017
Minority of patients with type 1 diabetes achieve ADA goals for glycemic control, study finds
Despite increasing adoption of insulin pumps and continuous glucose monitors, control of HbA1c hasn't necessarily improved, the authors noted.
https://diabetes.acponline.org/archives/2019/02/08/1.htm
8 Feb 2019
Cardiovascular event rates similar between once-weekly exenatide and placebo in patients with type 2 diabetes
A limitation of the industry-funded randomized trial was the high rate of early discontinuation: 43.0% of patients on exenatide and 45.2% of those on placebo.
https://diabetes.acponline.org/archives/2017/10/13/1.htm
13 Oct 2017
Rates of diabetes-related ESRD appear to decrease in U.S., Puerto Rico
From 2000 to 2014, the age-standardized incidence of end-stage renal disease (ESRD) attributed to diabetes decreased from 260.2 to 173.9 per 100,000 diabetic population.
https://diabetes.acponline.org/archives/2017/11/10/3.htm
10 Nov 2017
Risk score may help predict future glycemic control after new diagnosis of diabetes
The most important predictors of the trajectory of glucose control were body mass index and levels of HbA1c and triglycerides, according to the study of registry data from the Netherlands.
https://diabetes.acponline.org/archives/2017/12/08/3.htm
8 Dec 2017
Diabetes associated with fractures in older male veterans, with comorbidities as mediating factors
The retrospective study involved nearly 2.8 million male veterans 65 to 99 years of age, 32.3% with diabetes, who received primary care at Veterans Health Administration medical centers from 2000 to 2010.
https://diabetes.acponline.org/archives/2017/11/10/2.htm
10 Nov 2017
Dapagliflozin appears effective as adjunct therapy in patients with type 1 diabetes
Patients with type 1 diabetes taking dapagliflozin for 24 weeks had lower HbA1c level, body weight, and insulin dose than those on placebo, according to the industry-funded study.
https://diabetes.acponline.org/archives/2017/10/13/2.htm
13 Oct 2017
Type 1 diabetes associated with increased atrial fibrillation risk, particularly in women
Risk of atrial fibrillation increased with worse glycemic control and renal complications. Among patients with normoalbuminuria, researchers found no excess risk of atrial fibrillation with an HbA1c less than 9.7% for men or 8.8% for women.
https://diabetes.acponline.org/archives/2017/09/08/2.htm
8 Sep 2017
Insulin pumps reduced ketoacidosis, hypoglycemia in young patients with type 1 diabetes
The results provide further evidence that insulin pump therapy is safe and effective, even in routine diabetes care for unselected patients, according to the study authors.
https://diabetes.acponline.org/archives/2017/10/13/3.htm
13 Oct 2017
Updated ADA standards of diabetes care include focus on cardiovascular issues
The American Diabetes Association (ADA) recommends assessment of 10-year atherosclerotic cardiovascular disease (ASCVD) risk in patients with diabetes and discusses appropriate use of the ASCVD calculator.
https://diabetes.acponline.org/archives/2019/01/11/1.htm
11 Jan 2019